Salvage Treatment with Boceprevir-based Triple Therapy aft er Failed Treatment of Acute Hepatitis C with Dual Therapy

被引:0
|
作者
Mansour, Nabil [1 ]
El-Halabi, Mustapha [1 ]
Salyers, William [1 ]
机构
[1] Univ Kansas, Sch Med Wichita, Wichita, KS USA
来源
关键词
D O I
10.14309/00000434-201310001-01104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1104
引用
收藏
页码:S328 / S328
页数:1
相关论文
共 50 条
  • [31] A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy
    Takayama, Koji
    Furusyo, Norihiro
    Ogawa, Eiichi
    Shimizu, Motohiro
    Hiramine, Satoshi
    Mitsumoto, Fujiko
    Ura, Kazuya
    Toyoda, Kazuhiro
    Murata, Masayuki
    Hayashi, Jun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (9-10) : 577 - 581
  • [32] Influence of the inflammatory response on treatment of hepatitis C with triple therapy
    Winckler, Fernanda Cristina
    Marques Braz, Aline Marcia
    da Silva, Vanessa Nogueira
    Golim, Marjorie de Assis
    de Andrade, Vanessa Gutierrez
    de Abreu Machado, Paulo Eduardo
    de Arruda Silveira, Liciana Vaz
    Silva, Giovanni Faria
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2018, 51 (06) : 731 - 736
  • [33] A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
    Chen, Emerson Y.
    Sclair, Seth N.
    Czul, Frank
    Apica, Betty
    Dubin, Perry
    Martin, Paul
    Lee, William M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 1014 - +
  • [34] Efficacy and safety of boceprevir based triple therapy in Hungarian patients with hepatitis C genotype 1 infection, advanced stage fibrosis and prior treatment failure
    Hunyady Bela
    Abonyi Margit
    Csefko Klara
    Gervain Judit
    Haragh Attila
    Horvath Gabor
    Jancsik Viktor
    Makkai Erzsebet
    Mueller Zsofia
    Ribiczey Pal
    Sipos Bela
    Szabo Olga
    Szalay Ferenc
    Szentgyorgyi Laszlo
    Tornai Istvan
    Ujhelyi Eszter
    Varga Marta
    Weisz Gyorgy
    Makara Mihaly
    ORVOSI HETILAP, 2016, 157 (34) : 1366 - 1374
  • [35] Evaluation of Dual Versus Triple Therapy for Hepatitis C
    Brown, Nicol D.
    Browne, Barry A.
    Kim, Christine
    Jo, Chanhee
    Sears, Dawn
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2014, 6 (06) : 270 - 276
  • [36] Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program
    Litwin, Alain H.
    Soloway, Irene J.
    Cockerham-Colas, Lauren
    Reynoso, Sheila
    Heo, Moonseong
    Tenore, Christopher
    Roose, Robert J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1014 - 1019
  • [37] Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection
    Landaverde, Carmen
    Wells, Jennifer
    Hamner, Rebekah
    Goldstein, Janie L.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (04) : 419 - 429
  • [38] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [39] Information leaflets for patients with hepatitis C receiving treatment with triple therapy
    Yeste-Gomez, Ines
    Guadalupe Rodriguez-Gonzalez, Carmen
    Gimenez-Manzorro, Alvaro
    Ais-Larisgoitia, Arantza
    Sanjurjo-Saez, Maria
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (01): : 13 - 19
  • [40] Reactivation of pulmonary tuberculosis during treatment with triple therapy for hepatitis C
    Rodriguez-Martin, Laura
    Linares Torres, Pedro
    Aparicio Cabezudo, Marta
    Fernandez-Fernandez, Nereida
    Jorquera Plaza, Francisco
    Olcoz Goni, Jose Luis
    Gutierrez Gutierrez, Esperanza
    Fernandez Moran, Eva Maria
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (04): : 273 - 274